Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Five Oxford academics, including three from the Medical Sciences Division, are among fifty eminent scientists who have been elected as Fellows of the Royal Society for their exceptional contributions to science.

None © OUI/Greg Smolonski

This year’s Fellows are:

Sarah C. Darby, Professor of Medical Statistics, Nuffield Department of Population Health. Find out more

Véronique Gouverneur, Professor of Chemistry, Department of Chemistry.

Marta Kwiatkowska, Professor of Computing Systems, Department of Computer Science.

Anant Parekh, Professor of Physiology, Department of Physiology Anatomy & Genetics, and Director of the Centre for Integrative Physiology. Professor Anant said: ‘It is of course very humbling to receive such an honour. However, this really reflects the great support I’ve had from my department as well as the contributions from excellent young scientists I have been lucky enough to work with in my group over many years.’ Find out more

Matthew Rushworth, Professor of Cognitive Neuroscience, Department of Experimental Psychology. Find out more

 

Over the course of the Royal Society’s vast history, it is our Fellowship that has remained a constant thread and the substance from which our purpose has been realised: to use science for the benefit of humanity. This year’s newly elected Fellows and Foreign Members of the Royal Society embody this, being drawn from diverse fields of enquiry—epidemiology, geometry, climatology—at once disparate, but also aligned in their pursuit and contributions of knowledge about the world in which we live, and it is with great honour that I welcome them as Fellows of the Royal Society.

Venki Ramakrishnan, President of the Royal Society

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.